Why is fibrinogen reduced in hemophagocytic lymphohistiocytosis (HLH)?

Why Fibrinogen is Reduced in HLH

Fibrinogen is reduced in HLH primarily due to increased consumption from activated macrophages and cytotoxic T cells producing inflammatory cytokines (particularly IL-6 and TNF-α) that drive hepatic dysfunction and impair fibrinogen synthesis, combined with consumptive coagulopathy from disseminated intravascular coagulation (DIC) occurring in approximately 50% of cases 1.

Pathophysiologic Mechanisms

The hypofibrinogenemia in HLH results from a dual-hit mechanism:

1. Decreased Production

• The severe hyperinflammatory state with rampant cytokine secretion characteristic of HLH 2 directly impairs hepatic synthetic function
• Liver dysfunction is a cardinal feature of HLH, with activated macrophages infiltrating hepatic tissue and disrupting normal protein synthesis
• The cytokine storm (particularly IL-1, IL-6, TNF-α, and IFN-γ) interferes with the liver's ability to produce acute phase reactants, including fibrinogen

2. Increased Consumption

• DIC occurs in 50% of critically ill HLH patients 1, leading to accelerated fibrinogen consumption through widespread microvascular thrombosis
• Activated macrophages and endothelial dysfunction promote a prothrombotic state with simultaneous fibrinolysis
• The combination creates a consumptive coagulopathy that depletes fibrinogen stores faster than they can be replenished

Clinical Significance and Prognostic Value

Hypofibrinogenemia is not just a diagnostic marker—it's an independent predictor of mortality and severe bleeding in HLH:

• Fibrinogen <2 g/L is independently associated with:

  • Increased mortality (OR 2.42) 1
  • Severe bleeding complications (22% of patients) 1
  • Development of HLH in septic children (OR with cutoff <2.43 g/L) 3

• Fibrinogen <1.5 g/L occurs in approximately 52% of HLH patients 1, making it one of the most frequently reported coagulation abnormalities

Key Clinical Correlations

Hypofibrinogenemia in HLH is more severe in patients with:

• Infection-associated HLH (compared to autoimmune-associated) 4
• Immunocompromised status 1
• Histological evidence of hemophagocytosis 1
• Markedly elevated ferritin concentrations 1

Diagnostic and Monitoring Implications

Dynamic monitoring of fibrinogen levels is crucial for:

1. Early risk stratification: Fibrinogen <2.43 g/L has 72.41% sensitivity and 76.27% specificity for HLH diagnosis in septic children 3

2. Bleeding risk assessment: The only coagulation parameter significantly associated with severe bleeding is low fibrinogen (cutoff 2 g/L) 1

3. Prognostic evaluation: Serial measurements help track disease severity and response to treatment 4

Common Pitfalls to Avoid

• Don't dismiss mild hypofibrinogenemia: Even fibrinogen levels between 1.5-2.5 g/L warrant close monitoring, as levels can drop precipitously
• Don't attribute hypofibrinogenemia solely to DIC: Remember that impaired hepatic synthesis contributes significantly, even without overt DIC
• Don't overlook fibrinogen in sepsis: In children with sepsis and fibrinogen <2.43 g/L, actively evaluate for HLH/macrophage activation syndrome overlap 5
• Don't wait for all HLH-2004 criteria: Hypofibrinogenemia with hyperferritinemia and cytopenias should prompt immediate consideration of HLH, particularly in critically ill patients 1

Relationship to Other Coagulation Abnormalities

Hypofibrinogenemia typically occurs alongside:

• Prolonged PT and APTT 4, 1
• Elevated D-dimer 4
• Thrombocytopenia (universal in HLH) 1
• Elevated INR 4

However, fibrinogen remains the single most clinically relevant coagulation parameter for predicting both bleeding and mortality 1.